August 18, 2018 – By Mary Bollinger
WESTON GEORGE LTD PFD ORDINARY SHARES (OTCMKTS:WNGRF) had a decrease of 88.42% in short interest. WNGRF’s SI was 5,200 shares in August as released by FINRA. Its down 88.42% from 44,900 shares previously. With 8,200 avg volume, 1 days are for WESTON GEORGE LTD PFD ORDINARY SHARES (OTCMKTS:WNGRF)’s short sellers to cover WNGRF’s short positions. The SI to WESTON GEORGE LTD PFD ORDINARY SHARES’s float is 0.01%. It closed at $83.57 lastly. It is down 0.00% since August 18, 2017 and is . It has underperformed by 12.57% the S&P500.
Public Employees Retirement System Of Ohio increased Chemocentryx Inc (CCXI) stake by 68.82% reported in 2018Q1 SEC filing. Public Employees Retirement System Of Ohio acquired 47,911 shares as Chemocentryx Inc (CCXI)’s stock rose 32.26%. The Public Employees Retirement System Of Ohio holds 117,524 shares with $1.60M value, up from 69,613 last quarter. Chemocentryx Inc now has $555.68 million valuation. The stock increased 0.73% or $0.08 during the last trading session, reaching $11.03. About 163,923 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 83.50% since August 18, 2017 and is uptrending. It has outperformed by 70.93% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress
George Weston Limited engages in food processing and distribution business in Canada and internationally. The company has market cap of $10.17 billion. The companyÂ’s Weston Foods segment produces fresh, frozen, and specialty bakery products, including breads, rolls, bagels, flatbreads, rye bread, tortillas, doughnuts, cakes, pies, cookies, and crackers, and other baked goods through national and regional supermarkets, wholesale and club stores, dollar stores, convenience stores, food service distributors, and outlets. It has a 19.36 P/E ratio. This segment also supplies control brand products to retailers and consumer food companies; ice cream cones and sandwich wafers to manufacturers in the frozen novelty; and girl scout cookies.
Among 4 analysts covering ChemoCentryx (NASDAQ:CCXI), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. ChemoCentryx had 5 analyst reports since March 13, 2018 according to SRatingsIntel. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) has “Neutral” rating given on Tuesday, August 14 by JP Morgan. JP Morgan maintained the shares of CCXI in report on Tuesday, March 13 with “Overweight” rating.
Investors sentiment decreased to 1 in Q1 2018. Its down 0.30, from 1.3 in 2017Q4. It dropped, as 10 investors sold CCXI shares while 36 reduced holdings. 24 funds opened positions while 22 raised stakes. 24.22 million shares or 3.03% more from 23.51 million shares in 2017Q4 were reported. Northern Trust stated it has 276,280 shares. Acadian Asset Mngmt Ltd Llc stated it has 521,864 shares or 0.03% of all its holdings. Jacobs Levy Equity Mngmt Inc reported 15,708 shares. State Street Corporation, Massachusetts-based fund reported 424,832 shares. Smith Asset Gp Ltd Partnership has 0.01% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 26,447 shares. Trexquant Lp reported 11,574 shares. Metropolitan Life Ins Co reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Daiwa Securities Gru owns 269 shares. Banque Pictet & Cie holds 0.02% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 54,178 shares. Geode Cap Mngmt Ltd Liability Company accumulated 259,558 shares or 0% of the stock. Blackrock holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 2.57M shares. 20,300 are owned by Td Asset Mngmt Incorporated. Connor Clark & Lunn Investment Management Ltd stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). 20,000 are owned by Dekabank Deutsche Girozentrale. Wells Fargo And Com Mn owns 52,971 shares.
Since May 1, 2018, it had 0 buys, and 12 sales for $7.89 million activity. 2,709 shares valued at $35,217 were sold by Cappel Markus J. on Monday, May 21. On Monday, May 21 the insider Schall Thomas J. sold $1.19 million. On Tuesday, May 8 KANAYA SUSAN M sold $752,925 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) or 65,328 shares.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.